Connective tissue growth factor: What's in a name?

Citation
Eeda. Moussad et Dr. Brigstock, Connective tissue growth factor: What's in a name?, MOL GEN MET, 71(1-2), 2000, pp. 276-292
Citations number
106
Categorie Soggetti
Molecular Biology & Genetics
Journal title
MOLECULAR GENETICS AND METABOLISM
ISSN journal
10967192 → ACNP
Volume
71
Issue
1-2
Year of publication
2000
Pages
276 - 292
Database
ISI
SICI code
1096-7192(200009/10)71:1-2<276:CTGFWI>2.0.ZU;2-R
Abstract
Connective tissue growth factor (CTGF) is a member of the recently describe d CCN gene family which contains CTGF itself, cyr61, nov, elm1, Cop1, and W ISP-3. CTGF is transcriptionally activated by several factors although its stimulation by transforming growth factor beta (TGF-beta) has attracted con siderable attention. CTGF acts to promote fibroblast proliferation, migrati on, adhesion, and extracellular matrix formation, and its overproduction is proposed to play a major role in pathways that lead to fibrosis, especiall y those that are TGF-beta-dependent. This includes fibrosis of major organs , fibroproliferative diseases, and scarring. CTGF also appears to play a ro le in the extracellular matrix remodeling that occurs in normal physiologic al processes such as embryogenesis, implantation, and wound healing. Howeve r, recent advances have shown that CTGF is involved in diverse autocrine or paracrine actions in several other cell types such as vascular endothelial cells, epithelial cells, neuronal cells, vascular smooth muscle cells, and cells of supportive skeletal tissues. Moreover, in some circumstances CTGF has negative effects on cell growth in that it can be antimitotic and apop totic. In light of these discoveries, CTGF has been implicated in a diverse variety of processes that include neovascularization, transdifferentiation , neuronal scarring, atherosclerosis, cartilage differentiation, and endoch ondral ossification. CTGF has thus emerged as a potential important effecto r molecule in both physiological and pathological processes and has provide d a new target for therapeutic intervention in fibrotic diseases. (C) 2000 Academic Press.